FREMANEZUMAB (Ajovy®)

Clinical Indication

Prevention of migraine

Comments

In line with NICE TA631

Implementation date 3rd september 2020

Date of classification

August 2020

Review date

August 2020

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).